1. Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches.
- Author
-
Abulsoud, Ahmed I., Elshaer, Shereen Saeid, Rizk, Nehal I., Khaled, Reem, Abdelfatah, Amr M., Aboelyazed, Ahmed M., Waseem, Aly M., Bashier, Doha, Mohammed, Osama A., Elballal, Mohammed S., Mageed, Sherif S. Abdel, Elrebehy, Mahmoud A., Zaki, Mohamed Bakr, Elesawy, Ahmed E., El-Dakroury, Walaa A., Abdel-Reheim, Mustafa Ahmed, Saber, Sameh, and Doghish, Ahmed S.
- Abstract
Purpose of Review: To eradicate atherosclerotic diseases, novel biomarkers, and future therapy targets must reveal the burden of early atherosclerosis (AS), which occurs before life-threatening unstable plaques form. The chemical and biological features of microRNAs (miRNAs) make them interesting biomarkers for numerous diseases. We summarized the latest research on miRNA regulatory mechanisms in AS progression studies, which may help us use miRNAs as biomarkers and treatments for difficult-to-treat diseases. Recent Findings: Recent research has demonstrated that miRNAs have a regulatory function in the observed changes in gene and protein expression during atherogenesis, the process that leads to atherosclerosis. Several miRNAs play a role in the development of atherosclerosis, and these miRNAs could potentially serve as non-invasive biomarkers for atherosclerosis in various regions of the body. These miRNAs have the potential to serve as biomarkers and targets for early treatment of atherosclerosis. Summary: The start and development of AS require different miRNAs. It reviews new research on miRNAs affecting endothelium, vascular smooth muscle, vascular inflammation, lipid retention, and cholesterol metabolism in AS. A miRNA gene expression profile circulates with AS everywhere. AS therapies include lipid metabolism, inflammation reduction, and oxidative stress inhibition. Clinical use of miRNAs requires tremendous progress. We think tiny miRNAs can enable personalized treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF